Migraine Clinical Trial
Official title:
Randomised Controlled Crossover Double-blind Study on Very Low Calories Ketogenic Diet in Overweighted Migraine Patients.
Ketogenesis is a physiologic phenomenon due to starvation or ketogenic diet (KD), a drastic
restricted carbohydrate dietary regimen that induces lipid metabolism and ketone body (KB)
synthesis. We followed, in a dietician clinical setting, a group of migraineurs who randomly
received a one-month prescription of experimental diet, followed by a one-month of
carbohydrate progressive reintroduction, then another one-month of experimental diet,
followed by a one-month of carbohydrate progressive reintroduction. Experimental diets are a
very-low calorie KD, or an isocaloric non-ketogenic diet.
Aim of our study is verify if during ketogenesis migraine improves.
The ketogenic diet (KD) is a high-fat, low-carbohydrate diet for long used to treat
refractory epilepsy. Ketogenesis, ketone-body formation, is a physiologic phenomenon also
observed in patients following low-carbohydrate low-calorie diets for rapid weight loss.
Different Authors evidenced a protective effect of ketone bodies also on migraine; however,
KD effectiveness in this disorder is under scrutiny yet again. In fact, some concerns makes
the matter a still open question: available studies were anecdotal, or conducted on small
numbers; not all patients were diagnosed as migraineurs according to current headache
classification; during ketogenesis there could be an avoidance of potentially trigger foods.
Moreover, to comply with ketogenic diet, great motivation is needed and often migraineurs did
not have it.
Aim of this study is verify in a double blind parallel group cross over design if ketogenesis
is really able to prevent/avoid headache attacks in episodic migraineurs.
Methods: Thirty-five consecutive episodic migraineurs, with an attack frequency higher than 2
attacks per months, will be enrolled. Two different kind of diet, a KD and a standard
weight-loss diet (SD), will be consecutively administered in each patient recruited in the
study for one month. Randomly patients will start with KD or SD. At the end of the second
month differences between diets will be detected.
KD will consist of 4 daily pharmaceutical meal substitutes composed by low-carbohydrate,
low-fat, rich in protein serving of food, already commercially available. SD will consist in
a similar eating program, with serving of food with addition of carbohydrate to avoid
ketogenesis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06192173 -
Patent Foramen Ovale Closure in Migraine
|
||
Completed |
NCT05525611 -
Cabergoline as a Preventive Treatment for Chronic Migraine
|
N/A | |
Recruiting |
NCT03832998 -
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
|
Phase 3 | |
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Not yet recruiting |
NCT06428838 -
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
|
Phase 3 | |
Completed |
NCT06304675 -
Manageable Environmental Factors in Migraine
|
||
Completed |
NCT04084314 -
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
|
Phase 4 | |
Recruiting |
NCT05517200 -
Pilot Study for a Machine Learning Test for Migraine
|
||
Completed |
NCT04179474 -
Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
|
Phase 1 | |
Recruiting |
NCT04603976 -
Registry for Migraine - Clinical Core
|
Phase 4 | |
Completed |
NCT03597529 -
CHOCOlate MeLatonin for AdolescenT MigrainE
|
Phase 2 | |
Completed |
NCT04197349 -
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
|
Phase 1 | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Active, not recruiting |
NCT05064371 -
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
|
Phase 3 | |
Suspended |
NCT04069572 -
Vibratory Stimulation for the Treatment of Chronic Pain
|
N/A | |
Not yet recruiting |
NCT04859374 -
Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach
|
N/A | |
Not yet recruiting |
NCT03083860 -
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
|
N/A | |
Completed |
NCT02905227 -
A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder
|
Phase 1 | |
Enrolling by invitation |
NCT02532023 -
The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients
|
Phase 4 | |
Completed |
NCT02108678 -
One-Day Intervention for Depression and Impairment in Migraine Patients
|
N/A |